High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats

European Journal of Neuroscience

Volumn 26, Issue 6, 2007, Pages 1670-1680

  Lacombe, Emilie ^a,b   Carcenac, Carole ^a,b   Boulet, Sabrina ^a,b   Feuerstein, Claude ^a,b,c   Bertrand, Anne ^a,b   Poupard, Annie ^a,b   Savasta, Marc ^a,b,c  

^a INSERM   (France)

^b UNIV GRENOBLE ALPES   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Dopamine; High frequency stimulation; L 3, 4 dihydroxyphenylalanine treatment; Parkinson's disease; Subthalamic nucleus

Indexed keywords

DOPAMINE; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIATHERMY; DRUG EFFECT; DRUG MECHANISM; ELECTROSTIMULATION THERAPY; IN VIVO STUDY; MALE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS;

EID: 34548672558     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05747.x     Document Type: Article

References (99)

1. Abercrombie, E.D., Bonatz, A.E. Zigmond, M.J. (1990) Effects of l-Dopa on extracellular dopamine in striatum of normal and 6- hydroxydopamine-treated rats. Brain Res., 525, 36 44.
2. Abosch, A., Kapur, S., Lang, A.E., Hussey, D., Sime, E., Miyasaki, J., Houle, S. Lozano, A.M. (2003) Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Neurosurgery, 53, 1095 1102.
3. Anderson, M.E., Postupna, N. Ruffo, M. (2003) Effects of high-frequency stimulation in the internal globus pallidus on the activity of thalamic neurons in the awake monkey. JNeurophysiol., 89, 1150 1160.
4. Arbuthnott, G.W., Fairbrother, I.S. Butcher, S.P. (1990) Brain microdialysis studies on the control of dopamine release and metabolism in vivo. JNeurosci. Meth., 34, 73 81.
5. Bejjani, B.P., Gervais, D., Arnulf, I., Papadopoulos, S., Demeret, S., Bonnet, A.M., Cornu, P., Damier, P. Agid, Y. (2000) Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. JNeurol. Neurosurg. Psychiat., 68, 595 600.
6. Benabid, A.L., Benazzouz, A. Pollak, P. (2002) Mechanisms of deep brain stimulation. Mov. Disord., 17 (Suppl. 3 S73 S74.
7. Benazzouz, A., Piallat, B., Pollak, P. Benabid, A.L. (1995) Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci. Lett., 189, 77 80.
8. Benazzouz, A., Gao, D., Ni, Z. Benabid, A.L. (2000) High frequency stimulation of the STN influences the activity of dopamine neurons in the rat. Neuroreport, 11, 1593 1596.
9. Blanchard, V., Chritin, M., Vyas, S., Savasta, M., Feuerstein, C., Agid, Y., Javoy-Agid, F. Raisman-Vozari, R. (1995) Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain. JNeurochem., 64, 1669 1679.
10. Boulet, S., Lacombe, E., Carcenac, C., Feuerstein, C., Sgambato-Faure, V., Poupard, A. Savasta, M. (2006) Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata. JNeurosci., 26, 10768 10776.
11. Bruet, N., Windels, F., Bertrand, A., Feuerstein, C., Poupard, A. Savasta, M. (2001) High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats. JNeuropathol. Exp. Neurol., 60, 15 24.
12. Bruet, N., Windels, F., Carcenac, C., Feuerstein, C., Bertrand, A., Poupard, A. Savasta, M. (2003) Neurochemical mechanisms induced by high frequency stimulation of the subthalamic nucleus: increase of extracellular striatal glutamate and GABA in normal and hemiparkinsonian rats. JNeuropathol. Exp. Neurol., 62, 1228 1240.
13. Bunney, B.S., Aghajanian, G.K. Roth, R.H. (1973) Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat. New Biol., 245, 123 125.
14. Butcher, S.P., Fairbrother, I.S., Kelly, J.S. Arbuthnott, G.W. (1988) Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. JNeurochem., 50, 346 355.
15. Carman, L.S., Gage, F.H. Shults, C.W. (1991) Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res., 553, 275 283.
16. Chritin, M., Blanchard, V., Raisman-Vozari, R., Feuerstein, C., Agid, Y., Javoy-Agid, F. Savasta, M. (1996) DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration. Eur. J. Neurosci., 8, 2511 2520.
17. Contin, M., Riva, R., Martinelli, P., Procaccianti, G., Cortelli, P., Avoni, P. Baruzzi, A. (1990) Response to a standard oral levodopa test in parkinsonian patients with and without motor fluctuations. Clin. Neuropharmacol., 13, 19 28.
18. De la Fuente-Fernandez, R., Lu, J.Q., Sossi, V., Jivan, S., Schulzer, M., Holden, J.E., Lee, C.S., Ruth, T.J., Calne, D.B. Stoessl, A.J. (2001) Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover. Ann. Neurol., 49, 298 303.
19. Dentresangle, C., Le Cavorsin, M., Savasta, M. Leviel, V. (2001) Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra. Brain Res., 893, 178 185.
20. Dostrovsky, J.O. Lozano, A.M. (2002) Mechanisms of deep brain stimulation. Mov. Disord., 17 (Suppl. 3 S63 S68.
21. Ekesbo, A., Rydin, E., Torstenson, R., Sydow, O., Laengstrom, B. Tedroff, J. (1999) Dopamine autoreceptor function is lost in advanced Parkinson's disease. Neurology, 52, 120 125.
22. Fahn, S. (1974) 'On-off' phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine. Neurology, 24, 431 441.
23. Fairbrother, I.S., Arbuthnott, G.W., Kelly, J.S. Butcher, S.P. (1990a) In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals. I. Studies using veratrine and ouabain. JNeurochem., 54, 1834 1843.
24. Fairbrother, I.S., Arbuthnott, G.W., Kelly, J.S. Butcher, S.P. (1990b) In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals. II. Studies using potassium and tyramine. JNeurochem., 54, 1844 1851.
25. Fraix, V., Pollak, P., Van Blercom, N., Xie, J., Krack, P., Koudsie, A. Benabid, A.L. (2000) Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease. Neurology, 55, 1921 1923.
26. Garris, P.A. Wightman, R.M. (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. JNeurosci., 14, 442 450.
27. Graybiel, A.M., Hirsch, E.C. Agid, Y.A. (1987) Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity. Proc. Natl Acad. Sci. U.S.A., 84, 303 307.
28. Guesdon, J.L., Ternynck, T. Avrameas, S. (1979) The use of avidin-biotin interaction in immunoenzymatic techniques. JHistochem. Cytochem., 27, 1131 1139.
29. Heffner, T.G., Zigmond, M.J. Stricker, E.M. (1977) Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats. JPharmacol. Exp. Ther., 201, 386 399.
30. Hefti, F., Melamed, E. Wurtman, R.J. (1980) Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res., 195, 123 137.
31. Hefti, F., Enz, A. Melamed, E. (1985) Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs. Neuropharmacology, 24, 19 23.
32. Henning, J., Koczan, D., Glass, Ä., Karopka, T., Pahnke, J., Rolfs, A., Benecke, R. Gimsa, U. (2007) Deep brain stimulation in a rat model modulates TH, CaMKIIa and Homer1 gene expression. Eur. J. Neurosci., 25, 239 250.
33. Hilker, R., Voges, J., Ghaemi, M., Lehrke, R., Rudolf, J., Koulousakis, A., Herholz, K., Wienhard, K., Sturm, V. Heiss, W.D. (2003) Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov. Disord., 18, 41 48.
34. Hollerman, J.R. Grace, A.A. (1990) The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons. Brain Res., 533, 203 212.
35. Juncos, J.L., Engber, T.M., Raisman, R., Susel, Z., Thibaut, F., Ploska, A., Agid, Y. Chase, T.N. (1989) Continuous and intermittent levodopa differentially affect basal ganglia function. Ann. Neurol., 25, 473 478.
36. Kelly, R.S. Wightman, R.M. (1987) Detection of dopamine overflow and diffusion with voltammetry in slices of rat brain. Brain Res., 423, 79 87.
37. Kleiner-Fisman, G., Fisman, D.N., Sime, E., Saint-Cyr, J.A., Lozano, A.M. Lang, A.E. (2003) Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. JNeurosurg., 99, 489 495.
38. Krack, P., Limousin, P., Benabid, A.L. Pollak, P. (1997) Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease. Lancet, 350, 1676.
39. Krack, P., Hamel, W., Mehdorn, H.M. Deuschl, G. (1999) Surgical treatment of Parkinson's disease. Curr. Opin. Neurol., 12, 417 425.
40. Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P.D., Benazzouz, A., LeBas, J.F., Benabid, A.L. Pollak, P. (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med., 349, 1925 1934.
41. Kuhr, W.G., Bigelow, J.C. Wightman, R.M. (1986) In vivo comparison of the regulation of releasable dopamine in the caudate nucleus and the nucleus accumbens of the rat brain. JNeurosci., 6, 974 982.
42. Laihinen, A.O., Rinne, J.O., Nagren, K.A., Lehikoinen, P.K., Oikonen, V.J., Ruotsalainen, U.H., Ruottinen, H.M. Rinne, U.K. (1995) PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease. JNucl. Med., 36, 1263 1267.
43. Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D. Benabid, A.L. (1998) Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med., 339, 1105 1111.
44. Lopiano, L., Rizzone, M., Bergamasco, B., Tavella, A., Torre, E., Perozzo, P., Valentini, M.C. Lanotte, M. (2001) Deep brain stimulation of the subthalamic nucleus: clinical effectiveness and safety. Neurology, 56, 552 554.
45. Maeda, T., Kannari, K., Suda, T. Matsunaga, M. (1999) Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum. Brain Res., 817, 185 191.
46. Marsden, C.D. (1982) Basal ganglia disease. Lancet, 2, 1141 1147.
47. Marsden, C.D. Parkes, J.D. (1976) 'On-off' effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet, 1, 292 296.
48. Marshall, J.F. Teitelbaum, P.A. (1973) Comparison of the eating in response to hypothermic and glucoprivic challenges after nigral 6-hydroxydopamine and lateral hypothalamic electrolytic lesions in rats. Brain Res., 55, 229 233.
49. Maurice, N., Thierry, A.M., Glowinski, J. Deniau, J.M. (2003) Spontaneous and evoked activity of substantia nigra pars reticulata neuron during high-frequency stimulation of the subthalamic nucleus. JNeurosci., 23, 9929 9936.
50. McIntyre, C.C., Savasta, M., Kerkerian-Le Goff, L. Vitek, J.L. (2004) Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin. Neurophysiol., 115, 1239 1248.
51. Meissner, W., Reum, T., Paul, G., Harnack, D., Sohr, R., Morgenstern, R. Kupsch, A. (2001) Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. Neurosci. Lett., 303, 165 168.
52. Meissner, W., Harnack, D., Paul, G., Reum, T., Sohr, R., Morgenstern, R. Kupsch, A. (2002) Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats. Neurosci. Lett., 328, 105 108.
53. Meissner, W., Harnack, D., Reese, R., Paul, G., Reum, T., Ansorge, M., Kusserow, H., Winter, C., Morgenstern, R. Kupsch, A. (2003) High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats. JNeurochem., 85, 601 609.
54. Miller, D.W. Abercrombie, E.D. (1999) Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats. JNeurochem., 72, 1516 1522.
55. Miller, G.W., Staley, J.K., Heilman, C.J., Perez, J.T., Mash, D.C., Rye, D.B. Levey, A.I. (1997) Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann. Neurol., 41, 530 539.
56. Miller, G.W., Erickson, J.D., Perez, J.T., Penland, S.N., Mash, D.C., Rye, D.B. Levey, A.I. (1999) Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease. Exp. Neurol., 156, 138 148.
57. Mintz, I., Hammond, C., Guibert, B. Leviel, V. (1986) Stimulation of the subthalamic nucleus enhances the release of dopamine in the rat substantia nigra. Brain Res., 376, 406 408.
58. Molinuevo, J.L., Valldeoriola, F., Tolosa, E., Rumia, J., Valls-Sole, J., Roldan, H. Ferrer, E. (2000) Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch. Neurol., 57, 983 988.
59. Moro, E., Scerrati, M., Romito, L.M., Roselli, R., Tonali, P. Albanese, A. (1999) Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology, 53, 85 90.
60. Mouradian, M.M., Heuser, I.J., Baronti, F. Chase, T.N. (1990) Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease. Ann. Neurol., 27, 18 23.
61. Muenter, M.D. Tyce, G.M. (1971) L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects. Mayo Clin. Proc., 46, 231 239.
62. Naito, A. Kita, H. (1994) The cortico-nigral projection in the rat: an anterograde tracing study with biotinylated dextran amine. Brain Res., 637, 317 322.
63. Nakajima, T., Nimura, T., Yamaguchi, K., Ando, T., Itoh, M., Yoshimoto, T. Shirane, R. (2003) The impact of stereotactic pallidal surgery on the dopamine D2 receptor in Parkinson disease: a positron emission tomography study. JNeurosurg., 98, 57 63.
64. Nicholson, C. Rice, M.E. (1991) Diffusion of ions and transmitters in the brain cell microenvironment. In Fuxe, K. Agnati, L.F. (Eds), Volume Transmission in the Brain. Raven Press, New York, pp. 279 294.
65. Nimura, T., Yamaguchi, K., Ando, T., Shibuya, S., Oikawa, T., Nakagawa, A., Shirane, R., Itoh, M. Tominaga, T. (2005) Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study. JNeurosurg., 103, 968 973.
66. Nutt, J.G. Holford, N.H. (1996) The response to levodopa in Parkinson's disease: imposing pharmacological law and order. Ann. Neurol., 39, 561 573.
67. Nutt, J.G., Woodward, W.R., Carter, J.H. Gancher, S.T. (1992) Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon. Arch. Neurol., 49, 1123 1130.
68. Nutt, J.G., Carter, J.H. Woodward, W.R. (1995) Long-duration response to levodopa. Neurology, 45, 1613 1616.
69. Obeso, J.A., Rodriguez-Oroz, M.C., Rodriguez, M., Macias, R., Alvarez, L., Guridi, J., Vitek, J. DeLong, M.R. (2000) Pathophysiologic basis of surgery for Parkinson's disease. Neurology, 55, S7 S12.
70. Olanow, C.W. Obeso, J.A. (2000) Preventing levodopa-induced dyskinesias. Ann. Neurol., 47 (Suppl. 1 S167 S178.
71. Olanow, W., Schapira, A.H. Rascol, O. (2000) Continuous dopamine-receptor stimulation in early Parkinson's disease. Trends Neurosci., 23, S117 S126.
72. Olanow, C.W., Freeman, T. Kordower, J. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med., 345, 146 147.
73. Pahwa, R., Wilkinson, S.B., Overman, J. Lyons, K.E. (2005) Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease. Stereotact. Funct. Neurosurg., 83, 80 83.
74. Parkinson Study Group (2004) Levodopa and the progression of Parkinson's disease. N. Engl. J. Med., 351, 2498 2508.
75. Paul, G., Reum, T., Meissner, W., Marburger, A., Sohr, R., Morgenstern, R. Kupsch, A. (2000) High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat. Neuroreport, 11, 441 444.
76. Paxinos, G. Watson, C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
77. Pearson, J., Goldstein, M. Brandeis, L. (1979) Tyrosine hydroxylase immunohistochemistry in human brain. Brain Res., 165, 333 337.
78. Quattrone, A. Zappia, M. (1993) Oral pulse levodopa therapy in mild Parkinson's disease. Neurology, 43, 1161 1166.
79. Robinson, T.E. Whishaw, I.Q. (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA dopamine lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res., 450, 209 224.
80. Roth, R.H. (1979) Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors. Commun. Psychopharmacol., 3, 429 445.
81. Roth, R.H. (1984) CNS dopamine autoreceptors: distribution, pharmacology, and function. Ann. N.Y. Acad. Sci., 430, 27 53.
82. Salin, P., Manrique, C., Forni, C. Kerkerian-Le Goff, L. (2002) High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. JNeurosci., 15, 5137 5148.
83. Snyder, G.L., Keller, R.W. Jr. Zigmond, M.J. (1990) Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. JPharmacol. Exp. Ther., 253, 867 876.
84. Stachowiak, M.K., Keller, R.W. Jr., Stricker, E.M. Zigmond, M.J. (1987) Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage. JNeurosci., 7, 1648 1654.
85. Strafella, A.P., Paus, T., Fraraccio, M. Dagher, A. (2003a) Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human cortex. Brain, 126, 2609 2615.
86. Strafella, A.P., Sadikot, A.F. Dagher, A. (2003b) Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease. Neuroreport, 14, 1287 1289.
87. Torstenson, R., Hartvig, P., Langstrom, B., Westerberg, G. Tedroff, J. (1997) Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease. Ann. Neurol., 41, 334 340.
88. Tossman, U. Ungerstedt, U. (1986) Microdialysis in the study of extracellular levels of amino acids in the rat brain. Acta Physiol. Scand., 128, 9 14.
89. Uhl, G.R. Johnson, P.S. (1994) Neurotransmitter transporters: three important gene families for neuronal function. JExp. Biol., 196, 229 236.
90. Welter, M.L., Houeto, J.L., Tezenas du Montcel, S., Mesnage, V., Bonnet, A.M., Pillon, B., Arnulf, I., Pidoux, B., Dormont, D., Cornu, P. Agid, Y. (2002) Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain, 125, 575 583.
91. Westerink, B.H. Van Putten, F.M. (1987) Simultaneous determination of the rates of synthesis and metabolism of dopamine in various areas of the rat brain: application to the effects of (+)-amphetamine. Eur. J. Pharmacol., 133, 103 110.
92. Windels, F., Bruet, N., Poupard, A., Urbain, N., Chouvet, G., Feuerstein, C. Savasta, M. (2000) Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat. Eur. J. Neurosci., 12, 4141 4146.
93. Windels, F., Bruet, N., Poupard, A., Feuerstein, C., Bertrand, A. Savasta, M. (2003) Influence of the frequency parameter on extracellular glutamate and gamma-aminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in rats. JNeurosci. Res., 72, 259 267.
94. Windels, F., Carcenac, C., Poupard, A. Savasta, M. (2005) Pallidal origin of GABA release within the substantia nigra pars reticulata during high frequency stimulation of the subthalamic nucleus. JNeurosci., 25, 5079 5086.
95. Zappia, M., Colao, R., Montesanti, R., Rizzo, M., Aguglia, U., Gambardella, A., Oliveri, R.L. Quattrone, A. (1997) Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease. Ann. Neurol., 42, 245 248.
96. Zappia, M., Oliveri, R.L., Montesanti, R., Rizzo, M., Bosco, D., Plastino, M., Crescibene, L., Bastone, L., Aguglia, U., Gambardella, A. Quattrone, A. (1999) Loss of long-duration response to levodopa over time in PD: implications for wearing-off. Neurology, 52, 763 767.
97. Zigmond, M.J., Acheson, A.L., Stachowiak, M.K. Stricker, E.M. (1984) Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch. Neurol., 41, 856 861.
98. Zigmond, M.J., Berger, T.W., Grace, A.A. Stricker, E.M. (1989) Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism. Mol. Chem. Neuropathol., 10, 185 200.
99. Zigmond, M.J., Abercrombie, E.D., Grace, A.A. Stricker, E.M. (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci., 13, 290 295.